Abstract:Introduction: The incidence of biliary system diseases has been continuously increasing in the past decade. Biliary system diseases bring a heavy burden to humanity and society. However, the specific etiology and pathogenesis are still unknown. The biliary system, as a bridge between the liver and intestine, plays an indispensable role in maintaining the physiological metabolism of the body. Therefore, prevention and treatment of biliary diseases are crucial. It is worth noting that the microorganisms participate in the lipid metabolism of the bile duct, especially the largest proportion of intestinal bacteria. Methods: We systematically reviewed the intestinal microbiota in patients with gallstones (GS), non-calculous biliary inflammatory, and biliary tract cancer (BTC). And searched Pubmed, Embase and Web of science for research studies published up to November 2023. Results: We found that the abundance of Faecalibacterium genus is decreased in GS, primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC) and BTC. Veillonella, Lactobacillus, Streptococcus and Enterococcus genus were significantly increased in PSC, PBC and BTC. Interestingly, we found that the relative abundance of Clostridium was generally reduced in GS, PBC and BTC. However, Clostridium was generally increased in PSC. Discussion: The existing research mostly focuses on exploring the mechanisms of bacteria targeting a single disease. Lacking comparison of multiple diseases and changes in bacteria during the disease process. We hope to provide biomarkers forearly diagnosis of biliary system diseases and provide new directions for the mechanism of intestinal microbiota in biliary diseases.

Current research on the biliary tract diseases

Research on Biliary Diseases: Progresses and Challenges

Problems and reflections of biliary surgery

Current Advances in Treatment of Benign Biliary Stricture

Intestinal microbiota and biliary system diseases

Molecular Mechanisms of Hepatobiliary and Pancreatic Diseases in Patients with Inflammatory Bowel Disease

Controversy and consensus on diagnosis and treatment of benign diseases of biliary tract

The current status and outlook of bisic research about biliary tract cancers

Current Status of Diagnosis and Treatment of Primary Biliary Cholangitis and Related Challenges in China

Advances in hepatopancreatobiliary surgery of the 13th World Congress of the International Hepato-Pancreato-Biliary Association

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers

Advances in biliary tract cancer research from 2017 annual meeting of the American Society of Clinical Oncology

Advances in diagnosis and treatment of primary biliary cholangitis

Epidemiological, clinical and microbiological characteristics of patients with biliary tract diseases with positive bile culture in a tertiary hospital

The etiology, diagnosis, and therapy of biliary tract complication after liver transplantation

The Diagnosis and Treatment Status of Cholangiocarcinoma

Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases

Current Status and Evaluation of Endoscopic Treatment of Biliary Strictures

[Current Status and Challenges of Clinical Research and Development of New Drugs for Liver Diseases].

[Progress in clinical diagnosis and treatment of gallbladder cancer].

Which therapy in biliary tract cancer? Review of main concerns in diagnosis and choice of therapy in advanced setting, current standard, and new options